Axcend Awarded a Phase II SBIR Grant from the National Institutes of Health
Share Article
This Phase II SBIR Grant continues successful Phase I research by Axcend to develop a “Portable Liquid Chromatography Platform for Diverse Pharmaceutical Applications”
The Axcend Focus LC, Axcend s hand-portable, lightweight and compact capillary high-performance liquid chromatography (HPLC) system
We are honored to receive this Phase II SBIR grant and look forward to successfully developing and commercializing compact HPLC for pharmaceutical applications. PROVO, Utah (PRWEB) March 04, 2021
Axcend® today announced that it has been awarded a Phase II SBIR Grant to continue its work in developing a “Portable Liquid Chromatography Platform for Diverse Pharmaceutical Applications.”